by Jeffrey Stamberger | Aug 23, 2017 | Company News, HempMeds, Kannaway, Media Coverage
Medical Marijuana, Inc. and its subsidiaries Kannaway™ and HempMeds® were highlighted in a recent Forbes article revealing the outstanding growth of the CBD hemp oil industry, which is predicted to reach $1 billion within 3-5 years. According to the article, “hemp CBD...
by Jeffrey Stamberger | Apr 27, 2017 | Company News, Dixie Botanicals, HempMeds, Media Coverage, Scientific Research
[vc_row][vc_column][vc_column_text]Medical Marijuana, Inc. portfolio company HempMeds® just returned from Pittsburgh, Pennsylvania, where the company participated in the World Medical Cannabis Conference and Expo this past weekend. Hosted from Friday to Saturday,...
by Eve Ripley | Apr 26, 2017 | HempMeds, Press Releases
News highlights success of children using Company’s CBD hemp oil; features executives speaking on burgeoning medical cannabis industry. SAN DIEGO, April 26, 2017 — Medical Marijuana, Inc. (OTC: MJNA), the first publicly traded cannabis company in the...
by Eve Ripley | Feb 15, 2017 | HempMeds Brasil, Press Releases, Scientific Research
Article details the groundbreaking decision and possible implications for Alzheimer’s patients SAN DIEGO, Feb. 15, 2017 — Medical Marijuana, Inc. (OTC PINK:MJNA), the first-ever publicly traded Cannabis Company in the United States, subsidiary HempMeds®...
by Eve Ripley | Dec 15, 2016 | HempMeds, Press Releases
Company Continues International Expansion Initiatives with Company Formation in Chile and Begins Importing Real Scientific Hemp Oil(TM) to Argentinian Market SAN DIEGO, CA–(Marketwired – December 15, 2016) – Medical Marijuana, Inc. (OTC PINK: MJNA),...
